1	LHA	Doubly functionalized paromomycin pm-II-162	1.000
2	JS6	(1r,2r,3s,4r,6s)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-2-O-{2-[(2-phenylethyl)amino]ethyl}-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside	0.852
3	JS4	(2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-((2r,3r,4r,5s)-4-(2-(3-aminopropylamino)ethoxy)-5-((1r,2r,3s,5r,6s)-3,5-diam ino-2-((2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)-tetrahydro-2h-pyran-2-yloxy)-6-hydroxycyclohexyloxy)-2-( hydroxymethyl)-tetrahydrofuran-3-yloxy)-tetrahydro-2h-pyran-3,4-diol	0.730
4	NMZ	(2s)-4-amino-N-{(1r,2s,3r,4r,5s)-5-amino-3-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy }-4-[(2,6-diamino-2,4,6-trideoxy-4-fluoro-alpha-D-galactopyranosyl)oxy]-2-hydroxycyclohexyl}-2-hydroxybutanamide	0.730